Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06790771 · ClinicalTrials.gov registry record · NA
Effect of Supplement on Appetite and GLP-1
A NA study, sponsored by Texas Christian University.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT06790771 is a NA study that has completed, run by Texas Christian University. The registered enrollment target is 25 participants.
The verdict
NCT06790771, a NA study, has completed, sponsored by Texas Christian University.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Study Summary The goal of this study is to understand whether a dietary supplement containing L-arginine, resveratrol, tart cherry, and vitamin C reduces hunger and increases the release of GLP-1, a hormone associated with appetite suppression and improved glucose regulation. The study will also explore the metabolic effects of the supplement. Main Questions: 1. Does the supplement reduce hunger more effectively than a placebo? 2. Does it enhance GLP-1 release in individuals with overweight or obesity? Participants: * Age: 18-60 years * Body Mass Index (BMI): 25-40 kg/m² * Total participants: 25 * Must maintain usual eating and activity habits during the study. Study Design: * Conditions Tested: High-dose supplement, low-dose supplement, and placebo. * Participants will undergo three separate 2-hour lab visits, each after fasting for 8 hours. * During each visit: * Consume the assigned supplement or placebo. * Eat a standardized meal after a 60-minute rest. * Provide blood samples at eight time points to measure GLP-1 and other metabolic markers. * Rate hunger using a 7-point scale. Benefits and Risks: * Benefits: Participants may not directly benefit, but the findings could lead to new appetite-suppressing supplements that aid in weight loss. * Risks: Include discomfort from blood draws, possible gastrointestinal side effects from the supplement, and allergic reactions. Measures are in place to minimize these risks, such as pre-screening for allergies and using trained personnel for blood collection. This study is triple-blinded, meaning neither the participants, researchers, nor analysts will know which condition is being tested during each visit. Data collected will be anonymized to protect participant privacy.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT High Dose Supplement
- DIETARY_SUPPLEMENT Low Dose Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-01-15 |
| Est. Completion | 2026-03-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06790771
The ClinicalTrials.gov registry entry for NCT06790771 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Christian University, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT06790771 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06790771 about?
NCT06790771 is a clinical study titled "Effect of Supplement on Appetite and GLP-1". Study Summary The goal of this study is to understand whether a dietary supplement containing L-arginine, resveratrol, tart cherry, and vitamin C reduces hunger and increases the release of GLP-1, a hormone associated with appetite suppression and improved glucose regulation. The study will also ex...
What is the current status of trial NCT06790771?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2025-01-15. Estimated completion is 2026-03-15.
What interventions are being tested in trial NCT06790771?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), High Dose Supplement (DIETARY_SUPPLEMENT), Low Dose Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06790771?
This trial is sponsored by Texas Christian University, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.